Achieve Life Sciences, Inc. Liquidation Value
ACHV
Other
Cash & Equivalents
$20.93M
As of 2025-12-31
Current Price: $4.15 (as of 2026-04-24)
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $20.93M
Total Obligations: -$9.15M
$11.78M
Per share: $0.22
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $20.93M
AR: $0
Total Obligations: -$9.15M
$11.78M
Per share: $0.22
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $20.93M
AR: $0
Inventory: $0
Total Obligations: -$9.15M
$11.78M
Per share: $0.22
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $11.78M | $0.22 |
| Liquid Liquidation Value | $11.78M | $0.22 |
| Operating Liquidation Value | $11.78M | $0.22 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $20.93M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $9.08M |
| Long-term Debt | $15.00M |
| Op. Lease Liability | $66,000 |
| Finance Lease | N/A |
| Shares Outstanding | 53.2M |
Explore all 148 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $20.93M | N/A | N/A | N/A | $9.08M | N/A | $66,000 | N/A |
| 2025-09-30 | $31.93M | N/A | N/A | $1.94M | $9.73M | N/A | $80,000 | N/A |
| 2025-06-30 | $51.87M | N/A | N/A | $1.22M | $8.57M | N/A | $95,000 | N/A |
| 2025-03-31 | $13.02M | N/A | N/A | $1.66M | $7.13M | N/A | $109,000 | N/A |
| 2024-12-31 | $12.75M | N/A | N/A | $1.95M | $6.68M | N/A | $121,000 | N/A |
| 2024-09-30 | $9.54M | N/A | N/A | $1.01M | $6.72M | N/A | $22,000 | N/A |
| 2024-06-30 | $14.76M | N/A | N/A | $550,000 | $13.70M | $15.00M | $37,000 | N/A |
| 2024-03-31 | $66.40M | N/A | N/A | $373,000 | $20.57M | $15.00M | $53,000 | N/A |
▼ Community Notes